期刊文献+

多酶催化体系在医药化学品合成中的应用 被引量:2

Application of multi-enzyme catalytic system in the synthesis of pharmaceutical chemicals
下载PDF
导出
摘要 多酶催化体系成为近年来生物催化领域的研究热点。由于过程可控性及下游易分离的特性,越来越多的体外多酶催化体系已成功构建,部分体系还可耦合化学催化步骤,应用于精细化学品的合成。随着多酶催化体系构建技术的逐步成熟,将会给未来化工与医药类产品的生物制造带来广阔的应用前景。本文介绍了多酶催化体系的相关设计原则,通过对反应过程和合成路径进行热力学和动力学分析,设计高价值产物的生物合成路径,挖掘路径中的关键酶,结合各类新型组装策略将功能各异的酶级联组装成一个结构和功能整体,形成“底物通道”,减少中间体损失和降低副反应,实现从简单底物向复杂产物的高效生物转化。系统分析了多酶催化体系在医药化学品(如抗生素、抗癌药物、心血管疾病治疗药物、肝病治疗药物和精神疾病治疗药物及各类活性成分如D-葡萄糖二酸、萜类化合物和5-氨基乙酰丙酸)合成中的应用实例,并总结多酶催化体系仍存在的问题及可能的解决方法。 The multi-enzyme catalysis system has become a hotspot in the field of bio-catalysis in recent years.Due to the catalytic process's controllability and the ease of downstream separation,more and more intracellular metabolic pathways are being developed and applied to produce fine chemicals in vitro.With the gradual maturity of multi enzyme catalytic system construction technology,it will bring a broad application prospect for the manufacture of chemical products and pharmaceutical products in the future.In this regard,we review recently published examples of multi-enzyme catalysis,compare relevant design principles.Thermodynamics and kinetics of the reaction process and synthesis path analysis are used to design a bio-catalysis path.The critical enzymes are then mined in the pathway.By combining various assembly strategies,enzymes with different functions are cascaded into a whole structure and function unit to form a"substrate channel."Then intermediate loss and side reaction was reduced during the efficient bioconversion process from simple substrates to complex products.This method has the advantages of improving reaction efficiency,high regional selectivity and stereoselectivity,and also reducing environmental impact.Thus,biocatalysts are now widely used to produce valuable commercial chemicals,pharmaceuticals,and fuels.The target products could be obtained by the bio-catalysis process in vivo or in vitro.High-value products that are difficult to synthesize,or in an extremely complex synthesis pathway,or a very costly synthesis process by non-biological methods can now be produced in microbial hosts.To match the corresponding products,various genes in the host cell need to be optimized and fine-tuned.However,in vitro bio-catalysis can avoid these limitations.By adding a variety of enzymes to the reaction system,the product can be obtained after completing the catalysis at one time.Thus,industrial bio fabrication has emerged as an attractive and economically viable alternative to conventional large-scale chemical synthesis.The multi-enzyme catalysis system in the synthesis of pharmaceutical chemicals(such as antibiotics,drugs for anti-cancer,cardiovascular disease treatment,liver disease treatment and psychiatric treatment)and various active ingredients(such as D-gluconic acid,terpenoids,5-aminolevulinic acid)were discussed.The problems existing in the multi-enzyme catalytic system and the possible solutions are also summarized.
作者 汤恒 韩鑫 邹树平 郑裕国 TANG Heng;HAN Xin;ZOU Shuping;ZHENG Yuguo(National and Local Joint Engineering Research Center for Chiral Biomanufacturing,College of Biotechnology and Bioengineering,Zhejiang University of Technology,Hangzhou 310014,Zhejiang,China)
出处 《合成生物学》 CSCD 2021年第4期559-576,共18页 Synthetic Biology Journal
基金 国家重点研究计划(2019YFA0905000)。
关键词 生物催化 多酶催化体系 逆合成分析 无细胞 底物通道 固定化 biocatalysis multi-enzyme system retrosynthetic analysis cell-free substrate channel immobilization
  • 相关文献

参考文献2

二级参考文献47

  • 1吴海花,杨美玲,郭亚平,马恩波.中华稻蝗田间种群对马拉硫磷和溴氰菊酯的敏感性及其毒理机制的研究[J].农业环境科学学报,2006,25(3):623-628. 被引量:6
  • 2吴海花,杨美玲,郭亚平,陈月开,马恩波.不同中华稻蝗种群对马拉硫磷的敏感性及乙酰胆碱酯酶特性的比较[J].农业环境科学学报,2007,26(1):179-183. 被引量:5
  • 3王华弟,徐志宏,冯志全,徐福寿,吴玉香.稻田中华稻蝗发生动态、危害损失及防治指标[J].植物保护学报,2007,34(3):235-240. 被引量:4
  • 4宋凯.合成生物学导论.北京:科学出版社,2012.
  • 5Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Keasling JD. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature, 2006, 440:940-943.
  • 6Martin V J, Pitera DJ, Withers ST, Newman JD, Keasling JD. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature, 2003, 21:796-802.
  • 7Forster AC, Church GM. Towards synthesis of a minimal cell. Mol Syst Biol, 2006, 2:45.
  • 8Zhang YHP. Production of biocommodities and bioelectricity by cell-free synthetic enzymatic pathway biotransformations: challenges and opportunities. Biotechnol Bioeng, 2010, 105:663-677.
  • 9Zhang YHP, Sun J, Zhong JJ. Biofuel production by in vitro synthetic enzymatic pathway biotransformation. Curr Opin Biotechnol, 2010, 21 : 663-669.
  • 10Wang Y, Huang W, Sathitsuksanoh N, Zhu Z, Zhang YHP. Biohydrogenation from biomass sugar mediated by in vitro synthetic enzymaticpathways. Chem Biol, 2011, 18:372-380.

共引文献6

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部